PhytoHealth Corporation

Short Term Long Term Short Term Comparison Long Term Comparison
  • 4108
  • 1d-0.49%
  • 1w0.25%
  • 1m-2.88%
  • 1y4.11%
ATH
  • ATH Price$70.30
  • ATH Date2007-07-13
  • % since ATH-71.20%
  • % to ATH247.18%
ATL
  • ATL Price$10.18
  • ATL Date2020-03-23
  • % from ATL98.85%
  • Last Low Price$10.1834
  • Last Low Date2020-03-23
  • % From Last Low98.85%
IPO
  • IPO Price$58.00
  • % Current ROI USD-65.09%
  • ATH Price$70.30
  • % ROI ATH 69,037.65%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="4108"]

Key Data [addtoany]

Current price $20.25
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Today's High/Low $20.6/$20.25
Volume 188,343.00
Previous Close $20.35
52 Week High/Low $25.25/$18.8
Market Cap 4,041,896,960.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0
$20.25
[addtoany]

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements in Asia.
Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; NatoCleanse capsules, which helps to reduce the risk of cardiovascular diseases; ReyeasCleanse health food capsules; and EnerCharge, an energy drink.
The company also offers precision medical equipment and instruments; and computer-aided diagnosis development and authorization services.
PhytoHealth Corporation was founded in 1998 and is based in Taipei, Taiwan.

Annual Data | Millions of US $ except per share data 2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
Cash on hand ------------------
Receivables $5.01$9.08$11.76$6.03$36.45$102.51$111.90$94.22$60.09$63.21$76.07$69.68$31.64$3.25$1.74--$5.83
Inventory $122.56$97.14$88.43$72.54$74.34$40.83$95.65$56.26$3.17$5.55$0.79$0.90$0.03-$0.11---
Pre-Paid Expenses ------------------
Other Current Assets $0.14$742.08$0.36$0.64$2.39$31.15$22.24$37.73$54.19$31.63$68.50$12.90$65.61$272.26$16.85$9.25$11.69$3.79
Total Current Assets $920.20$1,049.77$1,278.01$1,465.36$1,339.66$1,432.14$1,726.17-----------
Property, Plant, And Equipment $445.58$463.53$429.36$467.68$483.11$498.27$505.88$531.27$498.06$346.83$222.12$4.42$5.43$7.18$12.95$5.19$5.01$5.75
Long-Term Investments $407.04$400.97$344.19$340.30$340.39$361.49$371.51-----------
Goodwill And Intangible Assets $31.18$31.18----------------
Other Long-Term Assets $3.02$18.30$17.24$3.09$21.44$26.50$32.01$23.35$26.74$21.86$21.82$30.76$4.25$27.70$266.65$0.79$0.47$34.55
Total Long-Term Assets $961.75$1,018.57$914.22$959.62--------------
Total Assets $1,881.95$2,068.34$2,192.23$2,424.98$2,339.83$2,489.18$2,823.92$2,883.22$1,650.41$1,906.84$2,165.87$1,077.37$1,555.56$1,352.16$1,210.95$305.18$344.09$156.02
Total Current Liabilities $100.90$87.48$70.09$51.70$42.80$97.44$79.47$93.77$80.31$76.98$154.68$65.61$30.30$27.29$20.34$9.97$8.36$5.09
Long Term Debt ------------------
Other Non-Current Liabilities $23.04$36.05$44.61$57.91$0.39$3.32$5.11$6.61$7.25$7.70-$7.75$5.69$3.62$2.17$0.90$3.68$0.11
Total Long Term Liabilities $29.31$36.05$44.61$57.91--------------
Total Liabilities $130.20$123.53$114.71$109.61$43.20$100.75$84.59$100.38$87.55$84.68$154.68$73.36$35.99$30.92$22.51$10.87$12.05$10
Common Stock Net $1,636.16$1,636.16$1,636.16$1,636.16$1,636.16$1,636.16$1,636.16$1,628.54$1,327.54$1,323.43$1,316.25$944.27$941.95$941.95$891.50$350$350$250
Retained Earnings (Accumulated Deficit) $-215.44$-90.93$-205.21$-193.82$-203.02$-322.77$-184.98-----------
Comprehensive Income ------------------
Other Share Holders Equity $-118.17$-130.39$-1.81$-5.80$-5.80$15.18$61.02-----------
Share Holder Equity $1,302.89$1,461.14$1,680.17$1,880.79$2,062.26$2,240.31$2,566.05$2,745.52$1,533.22$1,779.57$1,958.63$844.42$1,389.06$1,321.25$1,188.44$294.31$332.05$146.02
Total Liabilities And Share Holders Equity ------------------